Short-term zinc supplementation in women with non-insulin-dependent diabetes mellitus: Effects on plasma 5'-nucleotidase activities, insulin- like growth factor I concentrations, and lipoprotein oxidation rates in vitro

American Journal of Clinical Nutrition

Volumn 66, Issue 3, 1997, Pages 639-642

  Blostein Fujii, Ashley ^a   DiSilvestro, Robert A ^a   Frid, David ^a   Katz, Charles ^a   Malarkey, William ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

5' nucleotidase; Insulin like growth factor; Lipoprotein oxidation; Non insulin dependent diabetes; Women; Zinc

Indexed keywords

5' NUCLEOTIDASE; LIPOPROTEIN; SOMATOMEDIN C; ZINC;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FEMALE; HORMONE DETERMINATION; HUMAN; LIPID OXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; ZINC DEFICIENCY;

EID: 0030839525     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/66.3.639     Document Type: Article

References (28)

1. Thompson KH, Godin DV. Micronutrients and antioxidants in the progression of diabetes. Nutr Res 1995;15:1377-410.
2. Kinlaw WB, Levine AS, Morley HE, Silvis SE. McClain CJ. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 1983;75:273-7.
3. Golik A, Cohen N, Ramot Y, et al. Type II diabetes mellitus, congestive heart failure, and zinc metabolism. Biol Trace Elem Res 1993;39:171-5.
4. Sjogren A, Edvinsson L, Floren C-H, Abdulla M. Zinc and copper in striated muscle and body fluids from subjects with diabetes mellitus Type I. Nutr Res 1986;6:147-54.
5. Car N, Car A, Granic M, Skrabalo Z, Momcilovic B. Zinc and copper in the serum of diabetic patients. Biol Trace Elem Res 1992;32:325-9.
6. Aggett PJ, Comerford JG. Zinc and human health. Nutr Rev 1995;53(suppl):S16-22.
7. Jackson MJ. Physiology of zinc: general aspects. In: CF Mills, ed. Zinc in human biology. London: Springer-Verlag, 1989:1-14.
8. Bales CW, DiSilvestro RA, Currie KL, et al. Marginal zinc deficiency in older adults: responsiveness of zinc status indicators. J Am Coll Nutr 1994;13:455-62.
9. DiSilvestro RA, Blostein-Fujii A. Moderate zinc deficiency in rats enhances lipoprotein oxidation in vitro. Free Radic Biol Med 1997;22:739-42.
10. Jain SK, Mcvie R, Duett J, Herbst JJ. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 1989;38:1539-43.
11. Hunt JV, Smith CCT, Wolff SP. Autooxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 1990;39:1420-4.
12. Reaven PD. Mechanisms of atherosclerosis: role of LDL oxidation Adv Exp Med Biol 1994;366:113-28.
13. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
14. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophage that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979;76:333-7.
15. Steinberg D, Wittum JL. Lipoproteins and atherogenesis: current concepts. JAMA 1990;264:3047-52.
16. Oner G, Bhaumick B, Bala RM. Effect of zinc deficiency on serum somatomedin levels and skeletal growth in young rats. Endocrinology 1984;114:1860-3.
17. Ninh NX, Thissen J-P, Collette L, Gerard G, Khoi HH, Ketelslegers J-M. Zinc supplementation increases growth and circulating insulin-like growth factor I (IGF-I) in growth-retarded Vietnamese children. Am J Clin Nutr 1996;63:514-9.
18. Ninh NX, Thissen J-P, Maiter D, Adam E, Mulumba N, Ketelslegers J-M. Reduced liver insulin-like growth factor-I gene expression in young zinc-deprived rats is associated with a decrease in liver growth hormone (GH) receptors and serum GH-binding protein. J Endocrinol 1995;144:449-56.
19. McNall AD, Etherton TD, Fosmire GJ. The impaired growth induced by zinc deficiency in rats is associated with decreased expression of the hepatic insulin-like growth factor I and growth hormone receptor genes. J Nutr 1995;125:874-9.
20. Flyvbjerg A. Growth factors and diabetic complications. Diabet Med 1991;90:588-90.
21. Froesch ER, Hussain M. Recombinant human insulin-like growth factor-1: a therapeutic challenge for diabetes mellitus. Diabetologia 1994;37(suppl):S179-85.
22. Bertrand A, Buret J. A one-step determination of serum 5′-nucleotidase using a centrifugal analyzer. Clin Chim Acta 1982;119:275-84.
23. Finley PR, Shifman RB, William J, Lichti DA. Cholesterol in high density lipoprotein: use of Mg2+/dextran sulfate in its enzymic measurement. Clin Chem 1978;24:931-3.
24. Esterbauer H, Striegl, G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
25. Mateo M, Bustamante JB, DeQuiros JF, Manchad O. A study of the metabolism of zinc and its metalloenzymes in diabetes mellitus. Biomedicine 1975;23:134-6.
26. Lau AL, Failla ML. Urinary excretion of zinc, copper and iron in the streptozotocin-diabetic rat. J Nutr 1984;114:224-33.
27. Martin AM, Extremera BG, Soto MF, et al. Zinc levels after intravenous administration of zinc sulphate in insulin dependent diabetes mellitus patients. Klin Wochenschr 1991;69:640-4.
28. Tamborlane WV, Hintz RL, Bergman M. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels. N Engl J Med 1981;305:303-7.